Nanoligent (private company)
See something wrong or missing? Let us know
Offices:Barcelona
Business model:B2B
Nanoligent aim is the research and development to clinical phases of innovative cancer treatments based on protein nanoparticles.
Investors:
we tracked 6 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 16.99M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Nanoligent
Name | Criteria | |
---|---|---|
![]() |
Atai Life Sciences
77%
|
|
![]() |
Flow Neuroscience
77%
|
|
![]() |
Jutro Medical
77%
|
|
![]() |
Sano Genetics
77%
|
|
![]() |
Baseimmune
77%
|
|
![]() |
Causaly
77%
|
|
![]() |
Insempra
77%
|
|
![]() |
Xenothera
77%
|
|
![]() |
Formo
77%
|
|
![]() |
bit.bio
77%
|
|